Project Grant R01MH139486
- The National Institute of Mental Health awarded The General Hospital Corporation (Massachusetts General Hospital) $824,404 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop machine learning models that integrate clinician-conducted suicide risk assessments with electronic health record data to improve prediction of suicidal behavior and guide precision interventions in outpatient behavioral health settings. The research leverages routine clinical...
- The National Institute of Mental Health awarded the University of California, San Diego $199,271 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop a measurement-informed machine learning model for generalizable suicide risk prediction in youth. The project will create a transparent, interpretable, and developmentally sensitive machine learning model incorporating neurobiological, psychological, electronic health record-derived, and social indicators to...
- The National Institute of Mental Health awarded The General Hospital Corporation (doing business as Massachusetts General Hospital) $839,023 on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and validate computer vision techniques for suicide risk detection in emergency department settings. The award funds development of automated analysis of standardized skin images to identify and assess the severity of self-injury marks as predictors of prospective...
- The National Institute of Mental Health awarded The McLean Hospital Corporation $193,320 on February 18, 2026, under the Mental Health Research Grants program (CFDA 93.242, Assistance Listing) to support a K23 mentored career development award focused on online social networking mechanisms of suicide in adolescents. The award funds research establishing objective, ecologically valid assessment of interpersonal behavior in adolescents with suicidal thoughts and behaviors (STBS) through analysis...
- The National Institute of Mental Health awarded the University of Wisconsin - Madison $747,342 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct an examination of social connection in suicide risk during the college transition. The project leverages multimodal, high-resolution assessments to elucidate how social connection across digital and physical contexts contributes to suicide risk during the transition to college. The research will collect...
- The National Institute of Mental Health awarded New York University $435,974 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop computational models that quantify individual differences in learning and decision-making and predict psychiatric symptoms. The award funds development of a novel computational framework combining recurrent neural networks and dynamical systems theory to model reward learning processes at the individual level rather than group...
- The National Institute of Mental Health awarded The University of Chicago $719,592 on August 17, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a computational pharmacologic fMRI study examining the neurobiological mechanisms linking ovarian steroid hormones to suicidality in females. The study, titled "Parsing the Idiographic Neuroendocrinology of Suicidality (PINES)," combines clinical trial data, fMRI acquisition and analysis, and group iterative...
- The National Institute of Mental Health awarded The McLean Hospital Corporation $179,096 on June 18, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate neurocognitive mechanisms underlying negative retrieval bias in major depressive disorder. The recipient will conduct research to distinguish between two competing mechanisms that may explain how depression disrupts emotional memory: increased familiarity (depression strengthens evidence for all negative...
- The National Institute of Mental Health awarded Massachusetts General Hospital $197,578 on June 1, 2026, under the Mental Health Research Grants program (CFDA 93.242, K23MH144215) to investigate sleep and circadian timing irregularities as short-term risk factors for adolescent suicide through intensive longitudinal study. The research recruits 100 adolescents hospitalized for suicidal thoughts and behaviors, continuously monitoring objective sleep metrics via wrist actigraphy and collecting...
- The National Institute of Mental Health awarded the University of Wisconsin–Madison $1.644 million on June 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a mechanistic analysis of the transition from nonsuicidal to suicidal self-injury in adolescents. The research project will employ a multi-method longitudinal approach to follow adolescents aged 13–17 over a two-year period through February 28, 2031. The study aims to identify which factors predict...
The National Institute of Mental Health awarded Wellesley College $707,584 under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2026, to develop machine learning models that encode clinical knowledge for understanding, prediction, and prevention of suicide. The project addresses three data analysis bottlenecks in ecological momentary assessment studies of suicidal thoughts and behaviors: small sample sizes that limit deep learning applications, stochasticity in external triggering events that standard methods fail to model, and difficulty empirically testing verbal psychological theories of suicide. The research will encode qualitative clinical knowledge—intuitive knowledge difficult to mathematize—into deep learning methods to provide additional supervision, reduce reliance on limited data, incorporate clinical guidance in model discovery, and enable empirically testing psychological theories. Performance occurs in Wellesley Hills, Wellesley, Massachusetts, with a period of performance through May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $707.6k | 7/27/26 |